Forrest defines the parameters that are expected to drive the rate of resistance observed clinically and establish a quantitative estimate of risk of the emergence of drug resistance in clinical use to Pretomanid and a larger panel of compounds in development.
Wiktor’s research involves Fc glycosylation and how it impacts innate immune cell functionality.
Byron is highly motivated to provide advanced technical assistance for animal studies involving human pathogens across several laboratories within the department.
